Can I join a Cardiogen clinical trial?

No Cardiogen trial is recruiting right now. New trials appear on ClinicalTrials.gov.

Cardiogen clinical trials

Q: Are there clinical trials of Cardiogen?

ClinicalTrials.gov lists 1 registered trial of Cardiogen: 0 recruiting or about to, 0 running, 1 completed. The largest is Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning (155 people).

ClinicalTrials.gov lists 1 registered trial of Cardiogen: 0 recruiting or about to, 0 running, 1 completed. The largest is Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning (155 people).

1registered trials

0recruiting now

0running

1completed

0in phase 3

0with results posted

Completed 1

Cardiogen research (grade C)Cardiogen prices Search ClinicalTrials.gov

Where Cardiogen is in testing

Registered trials by phase. Phase 3 trials are the large ones that decide approval.

0Early phase 1First doses in people

0Phase 1Safety and dosing

0Phase 2Does it work?

0Phase 3Large confirmatory trials

0Phase 4After approval

1Not phasedObservational and other

Timeline

Each bar runs from a trial's start to its planned end; faded bars have no end date. Click a bar to open the trial.

RecruitingRunningCompletedStopped or withdrawnStatus unknownToday

Completed 1

Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning

Completed155 peopleBracco Diagnostics, Inc2011-09 → 2012-04🇺🇸 United States

Studying: Radiation Exposure · NCT01424774

About this trial

This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who were dosed at the end of use of the CardioGen-82® generators on the last day of generator use from the generator that was used immediately prior to the recalled generator (i.e., "target date generators"). These are not patients who received drug eluted from the recalled generator. Of these patients, it is planned that 100 patients will be entered in this trial.

Registered trials include ones that haven't published results yet. Trials are matched on the compound's name and code names (Cardiogen) in the listed interventions.